Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Bi-Sheng Liu"'
Autor:
Jeroen N Stoop, Bi-Sheng Liu, Jing Shi, Diahann T S L Jansen, Martin Hegen, Tom W J Huizinga, Leendert A Trouw, René E M Toes
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e102163 (2014)
ObjectiveThe immune response to post-translationally modified antigens is a key characteristic of rheumatoid arthritis. Carbamylation is such a posttranslational modification. Recently, we demonstrated that autoantibodies recognizing carbamylated pro
Externí odkaz:
https://doaj.org/article/b59842cee0e94863a8b2d99c5ea59403
Autor:
Yue-Yun Chen, Xu-De Yin, Ke Xie, Pei-Pei Wang, Yang Fu, Qing Li, Bi-Sheng Liu, Ting Liu, Zhen-Yu Ding
BackgroundIt’s widely accepted that Obesity is closely associated with the elevated risk of various cancers. However, there’s no consensus regarding the impact of body mass index (BMI) on the outcome of targeted therapy targeted-therapy efficacy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e0188c40a972fcf08f0de6c9e958709
https://doi.org/10.21203/rs.3.rs-75402/v1
https://doi.org/10.21203/rs.3.rs-75402/v1
Autor:
Hong‑Wei Xia, Qiyong Gong, Bi‑Sheng Liu, Qiu‑Lin Tang, Huan‑Ji Xu, Feng Bi, Yong‑Zhan Nie, Xin‑Yu Dai
Publikováno v:
Molecular Medicine Reports.
Dysregulation of epidermal growth factor receptor (EGFR) signaling is responsible for the resistance to EGFR tyrosine kinase inhibitors (TKIs), such as gefitinib and erlotinib, and is thereby associated with the progression of tumors in non‑small c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e99556f2bab7a0afffd56305ff0546c2
https://doi.org/10.3892/mmr.2018.9371
https://doi.org/10.3892/mmr.2018.9371
Autor:
Sheng Zhou, Yong‑Zhan Nie, Qiu‑Lin Tang, Na‑Xi Bi, Ji‑Tao Zhou, Qiyong Gong, Hong‑Wei Xia, Bi‑Sheng Liu, Qing Liu, Feng Bi
Publikováno v:
Oncology Reports.
Mutant KRAS and BRAF are associated with primary EGFR inhibitor resistance in colorectal cancer (CRC). However, other biomarkers that could predict EGFR inhibitor resistance remain elusive. In the present study, immunoblotting and cell proliferation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26297a77670f865254268e939e7499b3
https://doi.org/10.3892/or.2018.6630
https://doi.org/10.3892/or.2018.6630
Autor:
J. Dekkers, Tom W J Huizinga, Bi-Sheng Liu, Steve Rapecki, René E. M. Toes, Martin Hegen, Marije K. Verheul, Leendert A. Trouw, George M.C. Janssen, Arnoud H. de Ru, Peter A. van Veelen, Andreea Ioan-Facsinay, Jeroen N. Stoop
Publikováno v:
Annals of the Rheumatic Diseases, 76(8), 1449-1457
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases
ObjectivesOver 50% of patients with rheumatoid arthritis (RA) harbour a variety of anti-modified protein antibodies (AMPA) against different post-translationally modified (PTM) proteins, including anti-carbamylated protein (anti-CarP) antibodies. At
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bef3582edb7f235b61d9be4d3f52393a
https://hdl.handle.net/1887/114623
https://hdl.handle.net/1887/114623
Autor:
Fiona McPhee, Andre Boonstra, Rik A. de Groen, Bi-Sheng Liu, Jacques Friborg, Arjan Boltjes, Jun Hou, Harry L.A. Janssen
Publikováno v:
European Journal of Immunology. 45:250-259
With increasing interest in alternative options to interferon-alpha-based treatments, IFN-λ has shown therapeutic promise in a variety of diseases. Although the antiviral activity of IFN-λ has been extensively studied, there is limited knowledge re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0213a0d4addeefae63d7ff9c527f7f15
https://doi.org/10.1002/eji.201444903
https://doi.org/10.1002/eji.201444903
Publikováno v:
European Journal of Immunology. 42:2431-2440
Currently, only about 30-50% of chronic hepatitis C virus (HCV) and hepatitis B virus (HBV) patients respond to IFN-based therapy. It has been suggested that IL-10 is involved in suppressing the activity of type I IFNs on antigen-presenting cells (AP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::372c9c532ac9cd9c7fc6f6b3b67c8943
https://doi.org/10.1002/eji.201142360
https://doi.org/10.1002/eji.201142360
Publikováno v:
Journal of Leukocyte Biology, 89(6), 981-988. John Wiley & Sons Inc.
The consequences of chronic infection with the HCV on immunity to distinct pathogens are not fully appreciated, despite the potent modulatory effects of HCV on the immune system. We observed that upon TLR4 ligation, monocytes from chronic HCV patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::854fa84c86046098b90d0e0abaf7c168
https://doi.org/10.1189/jlb.1210680
https://doi.org/10.1189/jlb.1210680
Publikováno v:
Molecular Immunology, 48(12-13), 1505-1511. Elsevier Ltd.
Molecular Immunology, 48(12-13), 1505-1511. PERGAMON-ELSEVIER SCIENCE LTD
Molecular Immunology, 48(12-13), 1505-1511. PERGAMON-ELSEVIER SCIENCE LTD
Little is known about the frequency and function of CD16(+)CD14(-) monocytes from chronic HCV patients. We observed that the absolute numbers and ratio of CD16(+)CD14(-) to CD14(+)CD16(-) monocytes were similar between chronic HCV patients and health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb16a9e3d4cefc519298cafbeea87075
https://doi.org/10.1016/j.molimm.2011.04.008
https://doi.org/10.1016/j.molimm.2011.04.008
Publikováno v:
Blood, 117(8), 2385-2395. American Society of Hematology
The interferon-lambda (IFN lambda) family of cytokines, consisting of interleukin-28A (IFN lambda 2), IL-28B (IFN lambda 3), and IL-29 (IFN lambda 1), have been extensively studied for their antiviral activities. However, little is known about the ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::640604c82100e47d0ea238f54234100d
https://doi.org/10.1182/blood-2010-07-298976
https://doi.org/10.1182/blood-2010-07-298976